Showing results (491-500 of 649) with videos related to
Sort By:
Pageof 65
Human Genetics|December 1, 1993
Detection of a high mutation frequency in exon 12 of the porphobilinogen deaminase gene in patients with acute intermittent porphyriaC S Mgone, W G Lanyon, M R Moore, et al.Journal of Hepatology|January 1, 1991
Cholelithiasis in patients with variegate porphyriaA L Herrick, M R Moore, G G Thompson, et al.The Analyst|August 26, 1998
Speciation and absolute bioavailability: risk assessment of arsenic-contaminated sites in a residential suburb in CanberraJ C Ng, S M Kratzmann, L Qi, et al.Spine|January 1, 1995
The effect of instrumentation on human spinal fusion massJ B Kleiner, J A Odom, M R Moore, et al.British Medical Journal (Clinical Research Ed.)|February 15, 1986
Chester porphyria: a clinical study of a new form of acute porphyriaM R Qadiri, S E Church, K E McColl, et al.European Journal of Clinical Investigation|February 1, 1988
Effects of sodium valproate on haem biosynthesis in man: implications for seizure management in the porphyric patientG M McGuire, G J Macphee, G G Thompson, et al.Journal of Spinal Disorders|June 11, 1991
Analysis of factors related to truncal decompensation following Cotrel-Dubousset instrumentationM R Moore, G C Baynham, C W Brown, et al.Diabetes|December 1, 1989
Cytoplasmic retinoid-binding proteins and retinoid effects on insulin release in RINm5F beta-cellsB S Chertow, M R Moore, W S Blaner, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 18, 2003
Porphyrins as early biomarkers for arsenic exposure in animals and humansJ P Wang, L Qi, B Zheng, et al.Cancer Treatment Reports|November 1, 1979
Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancerC L Vogel, N H Love, D R East, et al.Pageof 65